Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for protection of ovarian reserve and function in breast cancer survivors treated with chemotherapy
ChiCTR1900023487Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ovarian injury and breast cancer comparing Placebo with Metformin (2 arms). Primary endpoints: Menstruation recovery rate and Disease-free survival. Started Oct 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
ovarian injurybreast cancer
Beyond the preview
Go deeper on ChiCTR1900023487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023487.